AJCC staging remains the foundation of melanoma care, yet a meaningful share of deaths arise in patients staged as lower risk. Dr. Singh examines where staging falls short and where molecular risk tools add clarity.
Integrating Gene Expression Profile Testing Into Clinical Decision-Making in Cutaneous Melanoma
Advertisement
Advertisement
Trending on Dermatology Times
1
ORKA-001 Achieves 61% Complete Skin Clearance in Psoriasis
2
FDA Accepts IND for Injectable rhPDGF-BB in Under-Eye Hollowing
3
Beyond Dry Skin: Rethinking Common Eczema Misconceptions
4
Type 2 Inflammation, Growth Curve, and HS Guidance for Advanced Practice
5